Long-range allosteric effects on the B to Z equilibrium by daunomycin

Area of Science:

• Molecular Biology
• Biophysics
• Drug Discovery

Background:

• DNA exists in various structural forms, including the B-form and the left-handed Z-form.
• The anticancer drug daunomycin interacts with DNA, but its precise mechanism of action is not fully understood.
• Alternating purine-pyrimidine sequences are known to undergo a transition between B-DNA and Z-DNA forms.

Purpose of the Study:

• To investigate the binding of daunomycin to specific DNA structures (poly[d(G-C)] and poly[d(G-m5C)]).
• To elucidate the effect of daunomycin binding on DNA conformation under varying solution conditions.
• To explore the potential allosteric mechanisms by which daunomycin influences DNA structure and function.

Main Methods:

• Spectroscopic and fluorometric techniques were employed to study drug-DNA interactions.
• Circular dichroism (CD) spectroscopy was used to monitor DNA structural changes.
• Sedimentation velocity and DNase I digestion assays assessed DNA structural transitions.

Main Results:

• Daunomycin binding to poly[d(G-C)] under high salt conditions (favoring Z-form) induced a cooperative binding process.
• The drug's binding acted as an allosteric effector, shifting the B-DNA to Z-DNA equilibrium.
• At high salt concentrations, daunomycin binding converted poly[d(G-C)] from Z-form to B-form, an effect observable over 20 base pairs.

Conclusions:

• Daunomycin binding can induce a significant structural transition (Z to B-form) in DNA.
• This allosteric effect, extending beyond the drug's direct binding site, may be crucial for its inhibitory action on DNA replication.
• Understanding these structural dynamics offers insights into the therapeutic mechanism of daunomycin.